Future of Longevity
Martin envisions a future where rigorous testing of aging clocks leads to the development of effective biomarkers within the next few years. He highlights the importance of clinical trials for potential therapies like Rapamycin and scenelytics, emphasizing the need for a systematic approach in drug discovery targeting aging mechanisms. With various startups and philanthropic efforts in play, the landscape for age-specific therapies is rapidly evolving, offering hope for significant advancements in longevity research.In this clip
From this podcast
Inner Cosmos with David Eagleman
Ep 81: How close are we to longevity? | INNER COSMOS WITH DAVID EAGLEMAN
Related Questions